Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,422.80
-18.40 (-1.28%)
Feb 4, 2026, 12:30 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 199.64 billion as of February 3, 2026. Its market cap has increased by 12.79% in one year.
Market Cap
199.64B
Enterprise Value
226.90B
Revenue
29.86B
Ranking
n/a
PE Ratio
47.32
Stock Price
1,422.80
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 199.64B, an increase of 141.38%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 199.64B | -2.66% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 365.31B |
| Ajanta Pharma | 347.92B |
| Gland Pharma | 312.63B |
| Emcure Pharmaceuticals | 278.69B |
| Wockhardt | 213.82B |
| Piramal Pharma | 205.90B |
| Alembic Pharmaceuticals | 153.72B |
| NATCO Pharma | 147.57B |